MicroRNA-323a-3p Negatively Regulates NEK6 in Colon Adenocarcinoma Cells

Abstract

Objective. The activity of NEK6 is enhanced in several cancer cells, including colon adenocarcinoma (COAD) cells. However, there are few reports on the microRNA (miRNA/miR) regulation of NEK6. In this study, we aimed to investigate the effects of miRNAs targeting NEK6 in COAD cells. Methods. Public data and online analysis sites were used to analyze the expression levels of NEK6 and miR-323a-3p in COAD tissues as well as the relationship between NEK6 or miR-323a-3p levels and survival in patients with COAD and to predict miRNAs targeting NEK6. Real-time polymerase chain reaction and western blotting were performed to determine the levels of NEK6 and miR-323a-3p in COAD cells. The targeting of NEK6 by miR-323a-3p was verified using a dual-luciferase reporter assay. The 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide assay, 5-ethynyl-2′-deoxyuridine assay, propidium iodide (PI) staining, annexin V-fluorescein isothiocyanate/PI staining, and transwell assay were employed to test the proliferation, apoptosis, migration ability, and invasiveness of COAD cells. Results. In COAD cells, NEK6 was highly expressed, whereas miR-323a-3p was expressed at low levels and negatively regulated NEK6. Upregulating the level of miR-323a-3p impaired the proliferation, migration, and invasion of COAD cells and promoted apoptosis, whereas supplementing NEK6 alleviated the damage of the proliferation, migration, and invasion of COAD cells caused by miR-323a-3p and inhibited miR-323a-3p-induced apoptosis. These findings indicate that miR-323a-3p regulates the proliferation, migration, invasion, and apoptosis of COAD cells by targeting NEK6. Conclusion. miR-323a-3p downregulates NEK6 in COAD cells; this provides a novel basis for further understanding the occurrence and development of COAD.

Prognostic value and immune infiltration of the NEK family in clear cell renal cell carcinoma

“…[37] NEK5 can facilitate the proliferation of BC cells [38,39] and the invasion of nasopharyngeal carcinoma (NPC). [40] NEK6 is overexpressed in several cancers, including THCA, [41] HCC, [42] BC, [43] PC, [12] colon adenocarcinoma, [44] and RCC. [45,46] In RCC, miRNA can promote the progression of RCC by targeting NEK6.…”

Prognostic value and immune infiltration of the NEK family in clear cell renal cell carcinoma

“…NEK6 is overexpressed in several cancers, including THCA [41], HCC [42], BC [43], PC [12], COAD [44], and RCC [45,46]. In RCC, miRNA can promote the progression of RCC by targeting NEK6.…”